Sanofi (SNY) Revenue (2009 - 2026)

Sanofi has disclosed Revenue across 18 years of filings, most recently posting $13.5 billion for Q2 2026.

• In Q2 2026, Revenue rose 19.16% year-over-year to $13.5 billion; the TTM figure through Jun 2026 stood at $53.6 billion (up 27.72% YoY), while the FY2025 annual figure was $50.8 billion, up 14.21% from the prior year.
• Revenue came in at $13.5 billion for Q2 2026 at Sanofi, up from $12.3 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $38.4 billion in Q4 2022 to a low of -$10.0 billion in Q4 2025.
• Average Revenue over 5 years is $12.7 billion, with a median of $10.9 billion recorded in 2022.
• The largest YoY upside for Revenue was 183.03% in 2025 against a maximum downside of 245.37% in 2025.
• Over 5 years, Revenue stood at $38.4 billion in 2022, then slumped by 84.13% to $6.1 billion in 2023, then climbed by 12.78% to $6.9 billion in 2024, then slumped by 245.37% to -$10.0 billion in 2025, then soared by 234.87% to $13.5 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $13.5 billion in Q2 2026, $12.3 billion in Q1 2026, and -$10.0 billion in Q4 2025.